Claims

Indicates the current processing state of a payment associated with a rheumatology specialty claim, such as pending, issued, posted, or denied. Used in revenue cycle management to track reimbursement progress for rheumatology services including biologics administration and chronic autoimmune disease treatment.

Documents the body systems reviewed during a rheumatology clinical evaluation, focusing on musculoskeletal, integumentary, and immunological systems. Captured as part of the Review of Systems in rheumatology encounters to support diagnosis of conditions such as rheumatoid arthritis, lupus, and gout.

The date on which a rheumatology specialty service was delivered to the patient, such as a consultation, biologic infusion, joint injection, or disease monitoring visit. Used in claims adjudication, care gap analysis, and chronic disease management reporting for autoimmune and musculoskeletal conditions.

The date on which a claim for inpatient room and board charges was submitted to the payer for adjudication. Used in hospital billing and revenue cycle management to track timely filing compliance and processing timelines for facility-based accommodation charges billed on UB-04 claim forms.

The current adjudication state of a claim for inpatient room and board charges, such as submitted, pending, approved, denied, or adjusted. Used in hospital revenue cycle management to monitor billing progress for facility accommodation charges submitted on institutional UB-04 claim forms.

The dollar amount paid by the payer or member for inpatient room and board charges, including daily accommodation fees billed on UB-04 institutional claims. Used in hospital revenue cycle reporting to reconcile facility reimbursements against contracted per-diem or DRG-based rates for inpatient stays.

Indicates the current processing state of a payment associated with inpatient room and board charges, such as pending, issued, posted, or denied. Used in hospital revenue cycle management to track reimbursement progress for facility accommodation charges billed on UB-04 institutional claims.

Dollar amount applied to modify the originally billed or paid amount on a pharmacy or medical claim where drug administration route (oral, IV, subcutaneous, etc.) affects reimbursement calculation. Captures payer-initiated corrections tied to route-specific pricing or coverage rules.

Date a pharmacy or medical claim was submitted to the payer where the drug administration route (oral, IV, topical, inhaled, etc.) is a determinant of coverage or reimbursement. Used to establish claim timelines and adjudication sequencing for route-differentiated services.

Current adjudication state of a pharmacy or medical claim where drug administration route influences benefit determination. Status values typically include submitted, pending, approved, denied, or adjusted, reflecting payer processing outcomes for route-specific coverage rules.

Member cost-sharing amount applied toward the deductible on claims where drug administration route (IV, oral, subcutaneous, etc.) determines benefit tier placement. Some plans apply different deductible thresholds based on whether a drug is administered in a clinical vs. self-administered setting.

Actual dollar amount paid by the payer on a pharmacy or medical claim where drug administration route (oral, IV, inhaled, etc.) is a factor in reimbursement rate determination. Reflects post-adjudication payment after applying route-based fee schedules, edits, and member cost-sharing.

Processing state of the payer's financial disbursement on a claim where drug administration route affects reimbursement eligibility. Status values such as pending, issued, denied, or reversed indicate whether payment has been released for route-specific services billed on the claim.

Clinical review of body systems relevant to determining or validating the appropriate drug administration route (oral, IV, subcutaneous, intramuscular, etc.) for a patient. Supports medical necessity documentation and prior authorization workflows where route selection requires clinical justification.

Date on which a drug or therapeutic agent was administered via a specific route (oral, IV, subcutaneous, topical, etc.) as recorded on the claim or clinical encounter. Used to align pharmacy or infusion service events with billing periods and episode-of-care timelines.

Dollar amount applied to modify the originally billed or paid amount on a laboratory or pathology claim associated with a biological specimen (blood, tissue, urine, etc.). Reflects payer corrections related to sample type coding, duplicate billing, or fee schedule discrepancies for specimen-based testing services.

Date a laboratory or pathology claim was submitted to the payer for processing and adjudication of services performed on a collected biological specimen. Used to track claim submission timelines, filing deadlines, and adjudication lag for specimen-based diagnostic services.

Current adjudication state of a laboratory or pathology claim submitted for services performed on a biological specimen such as blood, urine, or tissue. Status values including submitted, pending, approved, denied, or adjusted reflect payer processing outcomes for specimen-based diagnostic testing claims.

Member cost-sharing amount applied toward the plan deductible on a laboratory or pathology claim for diagnostic testing performed on a collected biological specimen. Amount varies based on benefit design, network status of the lab, and whether the specimen collection is part of a preventive or diagnostic service.

Actual dollar amount disbursed by the payer for laboratory or pathology services performed on a collected biological specimen after adjudication. Reflects post-processing payment net of member cost-sharing, contractual adjustments, and any specimen-specific fee schedule rates applied to the claim.